CONTROLLED SUB. PRESCRIPTION; HOSPICE                                         H.B. 4225 (S-1):

                                                                                                    SUMMARY OF BILL

                                                                                     REPORTED FROM COMMITTEE

House Bill 4225 (Substitute S-1 as reported)

Sponsor:  Representative Bronna Kahle

House Committee:  Health Policy

                             Ways and Means

Senate Committee:  Health Policy and Human Services

CONTENT

The bill would amend Part 73 (Manufacture, Distribution, and Dispensing) of the Public Health Code to specify that a prohibition against a licensed prescriber's prescribing a controlled substance listed in Schedules 2 to 5 unless he or she is in a bona fide prescriber-patient relationship with the patient for whom the controlled substance is being prescribed would not apply to a patient who was under the care of a hospice.

The bill also would specify that a requirement for a licensed prescriber to obtain and review a Michigan Automated Prescription System (MAPS) report before prescribing or dispensing more than a three-day supply of a controlled substance would not apply if the patient were the patient of a hospice and the prescriber had obtained and reviewed the MAPS report when the patient was admitted to the hospice.

The bill is tie-barred to Senate Bill 128. (Senate Bill 128 (S-1) would modify the definition of "bona fide prescriber-patient relationship".)

MCL 333.7303a                                                       Legislative Analyst:  Tyler VanHuyse

FISCAL IMPACT

The bill would have no fiscal impact on State or local government.

Date Completed:  5-20-19                                        Fiscal Analyst:  Elizabeth Raczkowski

This analysis was prepared by nonpartisan Senate staff for use by the Senate in its deliberations and does not constitute an official statement of legislative intent.